Jiangsu, China

Shuqin Yu



Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 14(Granted Patents)


Company Filing History:


Years Active: 2012-2014

Loading Chart...
Loading Chart...
4 patents (USPTO):

Title: The Innovations of Shuqin Yu: Pioneering Docetaxel-Cyclodextrin Inclusion Complexes

Introduction

Shuqin Yu is a talented inventor based in Jiangsu, China, who has made significant contributions to the field of pharmaceuticals. With a remarkable portfolio of four patents, she has dedicated her research to developing innovative solutions that enhance drug solubility and stability.

Latest Patents

One of Shuqin Yu's most notable inventions is the pharmaceutical composition containing docetaxel-cyclodextrin inclusion complex, aimed at improving the water-solubility and stability of docetaxel. Her method involves creating a docetaxel inclusion complex that can achieve a water solubility of up to 15 mg/ml, with a stability constant of Ka=2056 M-13051 M. This complex consists of docetaxel combined with hydroxypropyl-beta-cyclodextrin and/or sulfobutyl-beta-cyclodextrin in a ratio ranging from 1:10 to 150. The process includes dissolving docetaxel in ethanol and adding it to a cyclodextrin solution, followed by various filtration and drying steps to yield the inclusion complex in either liquid or solid form.

Career Highlights

Throughout her career, Shuqin Yu has worked with esteemed organizations, including Hainan Hdeton Science and Technology Co., Ltd. and Meridian Laboratories, Inc. Her role in these companies has allowed her to apply her innovative concepts in practical settings, fostering developments that hold the potential to positively impact patient care.

Collaborations

Shuqin has collaborated with prominent colleagues in her field, including Yong Ren and Jianfeng Gao. These partnerships have further enriched her research endeavors and have been instrumental in driving the advancement of her patented technologies.

Conclusion

In conclusion, Shuqin Yu's contributions to the field of pharmaceuticals, particularly through her patented docetaxel-cyclodextrin inclusion complex, exemplify her commitment to innovation in drug development. Her work not only enhances the solubility and stability of essential medications but also signifies the potential for improved therapeutic outcomes for patients globally.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…